fenofibrate and Recrudescence

fenofibrate has been researched along with Recrudescence in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barshop, BA; Jones, KL; Vivatrat, N	1
Lipsker, D; Lutz, V	1
Ball, SG; Feher, MD; Hepburn, AL; Hogarth, MB; Kaye, SA	1

Trials

1 trial(s) available for fenofibrate and Recrudescence

Article	Year
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. Rheumatology (Oxford, England), 2003, Volume: 42, Issue:2 Topics: Acute Disease; Adult; Aged; Alkaline Phosphatase; Allopurinol; Arthritis, Gouty; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Fenofibrate; Gout; Gout Suppressants; Humans; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Recurrence; Uric Acid	2003

Article

Year

Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.

Rheumatology (Oxford, England), 2003, Volume: 42, Issue:2

Topics: Acute Disease; Adult; Aged; Alkaline Phosphatase; Allopurinol; Arthritis, Gouty; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Fenofibrate; Gout; Gout Suppressants; Humans; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Recurrence; Uric Acid

2003

Other Studies

2 other study(ies) available for fenofibrate and Recrudescence

Article	Year
Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia. American journal of medical genetics. Part A, 2009, Volume: 149A, Issue:11 Topics: Apolipoproteins E; Biopsy; Child, Preschool; Female; Fenofibrate; Glycogen Storage Disease Type I; Humans; Hyperlipoproteinemia Type III; Hypertriglyceridemia; Infant; Lipids; Liver; Liver Transplantation; Pancreatitis, Chronic; Recurrence	2009
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra. Archives of dermatology, 2012, Volume: 148, Issue:3 Topics: Acitretin; Acrodermatitis; Antirheumatic Agents; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypertriglyceridemia; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Keratolytic Agents; Middle Aged; Psoriasis; Receptors, Interleukin-1; Recombinant Proteins; Recurrence; Triglycerides; Tumor Necrosis Factor-alpha	2012

Article

Year

Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia.

American journal of medical genetics. Part A, 2009, Volume: 149A, Issue:11

Topics: Apolipoproteins E; Biopsy; Child, Preschool; Female; Fenofibrate; Glycogen Storage Disease Type I; Humans; Hyperlipoproteinemia Type III; Hypertriglyceridemia; Infant; Lipids; Liver; Liver Transplantation; Pancreatitis, Chronic; Recurrence

2009

Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.

Archives of dermatology, 2012, Volume: 148, Issue:3

Topics: Acitretin; Acrodermatitis; Antirheumatic Agents; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypertriglyceridemia; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Keratolytic Agents; Middle Aged; Psoriasis; Receptors, Interleukin-1; Recombinant Proteins; Recurrence; Triglycerides; Tumor Necrosis Factor-alpha

2012